Upgrade to SI Premium - Free Trial

CytomX Therapeutics (CTMX) PT Lowered to $14 at Guggenheim

August 10, 2026 7:28 AM
(Updated - August 10, 2026 7:40 AM EDT)

Guggenheim analyst Michael Sch lowered the price target on CytomX Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change